Clinical Trial Update: Bortezomib and Gemcitabine in Treating Patients With Relapsed B-Cell Non-Hodgkin Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for bortezomib and gemcitabine in relapsed B-cell non-Hodgkin lymphoma (Phase 1/Phase 2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Non-hodgkin Lymphoma
• Non-hodgkin Lymphoma

Drugs mentioned

• Bortezomib (bortezomib)
• Gemcitabine (Gemcitabine)

Snippet

Sponsor: City of Hope Medical Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-03-21